NCT02966912View on ClinicalTrials.gov

Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

September 30, 2019

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

400 mg of Magnesium Oxide twice daily for 24 weeks

OTHER

Open label (none)

Trial Locations (1)

02908

Providence VA Medical Center, Providence

All Listed Sponsors
lead

Providence VA Medical Center

FED

NCT02966912 - Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity | Biotech Hunter | Biotech Hunter